Boston Imaging, NeuroLogica Rebrand Under Samsung HME America

Samsung Medison announced that its U.S. medical imaging businesses, previously operating as NeuroLogica and Boston Imaging, will unify under a new Samsung HME (Healthcare and Medical Equipment) America corporate identity.

The transition brings the company’s U.S. ultrasound, digital radiography, and computed tomography (CT) operations under one integrated structure.

This announcement follows significant growth in the company’s medical imaging portfolio, fueled by expanded product innovation, organizational investment, and deeper engagement with health systems nationwide.

Recent advancements from Samsung HME America include the Samsung R20 and Z20 ultrasound systems, designed to deliver enhanced image quality and AI-powered tools that support more confident clinical decision-making. The company has also continued to expand its AI capabilities through the Samsung acquisition of Sonio, a French AI-powered prenatal ultrasound startup specializing in early-stage fetal abnormality detection.

The company is also advancing and expanding its digital radiography portfolio with innovations focused on dose reduction and workflow enhancements.

“This milestone represents more than a name change,” said Kyu Tae Yoo, CEO of Samsung Medison and division head of Samsung HME at Samsung Electronics. “It reinforces Samsung’s long-term commitment to healthcare providers nationwide and reflects the growth and maturity of our U.S. medical imaging organization. Our growth has been powered by listening closely to our customers and translating real clinical challenges into innovation at a pace rarely seen in healthcare; and we will continue along this path.”